DaVita Retained Earnings (Accumulated Deficit) 2010-2024 | DVA

DaVita retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $1.061B, a 126.28% increase year-over-year.

  • DaVita retained earnings (accumulated deficit) for 2023 were $0.598B, a 242.88% increase from 2022.
  • DaVita retained earnings (accumulated deficit) for 2022 were $0.174B, a 50.76% decline from 2021.
  • DaVita retained earnings (accumulated deficit) for 2021 were $0.354B, a 58.44% decline from 2020.

DaVita Retained Earnings (Accumulated Deficit) 2010-2024 | DVA

  • DaVita retained earnings (accumulated deficit) for 2023 were $0.598B, a 242.88% increase from 2022.
  • DaVita retained earnings (accumulated deficit) for 2022 were $0.174B, a 50.76% decline from 2021.
  • DaVita retained earnings (accumulated deficit) for 2021 were $0.354B, a 58.44% decline from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$17.3B
Encompass Health (EHC)$9.3B
Chemed (CHE)$8.7B
Elanco Animal Health (ELAN)$7.2B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$5B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.8B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1B
Atai Life Sciences (ATAI)$208M
Daxor (DXR)$45M
ATI Physical Therapy (ATIP)$25M
MEDIROM Healthcare Technologies (MRM)$19M
Psychemedics (PMD)$14M
Ontrak (OTRK)$10M
Novo Integrated Sciences (NVOS)$6M
IMAC Holdings (BACK)$2M